secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiniMed Group, Inc. (MMED)
CIK:        0002062583
Form:       8-K
Filed at:   2026-06-29T13:22:39+00:00
Accession:  0001104659-26-078588
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.08, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MiniMed expands board to 11; appoints David Endicott (Alcon CEO) and Linnea Burman (Medtronic SVP)
--------------------------------------------------------------------------------

- Board increased from 9 to 11; appointments effective June 29, 2026.
- David Endicott (Alcon CEO) appointed as class I director, independent, will serve on Compensation and Talent Committee.
- Linnea Burman (Medtronic SVP, Neurovascular) appointed as class II director; no compensation while Medtronic is affiliate.
- 2026 annual meeting set for Oct 9, 2026; record date Aug 11, 2026; stockholder proposals due July 26, nominations due July 17.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2062583/000110465926078588/0001104659-26-078588-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2062583/000110465926078588/tm2619270d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-078588

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer